AXSM logo

AXSOME THERAPEUTICS INC

AXSMNASDAQ
🏆 #650 by market capEarnings Nov 9US Equity
$215.77▼ $5.01 (−2.32%)
🌙 After hours$215.35▼ 0.19%Regular close · extended-hours price shown
1h—
24h▼ 2.3%
7d▲ 1.4%
14d▼ 5.1%
30d▼ 5.4%
1y▲ 105.2%
🏦Market Cap
$11.10B
Mid Cap
📈Revenue Growth (YoY)
+63.9%
High Growth
📊Gross Margin
92.6%
High
💵FCF Margin
—
⚖️P/S Ratio
15.9x
Expensive
Otter Score
61
Fair
📊

Analyst Ratings

Price
$215.77
Total
26
Raised
0
Lowered
0
Avg PT
$269.53
H / L
$380 / $200
InstitutionActionRatingDate
Mizuho
ReiteratedOutperform2026-07-31
HC Wainwright & Co.
ReiteratedBuy2026-07-15
RBC Capital
ReiteratedOutperform2026-07-07
TD Cowen
ReiteratedBuy2026-06-17
Needham
ReiteratedBuy2026-05-05
Morgan Stanley
ReiteratedEqual Weight2026-05-05
Wells Fargo
ReiteratedOverweight2026-05-05
Guggenheim
ReiteratedBuy2026-05-05
Baird
ReiteratedOutperform2026-05-05
Jefferies
ReiteratedBuy2026-05-04
UBS
ReiteratedBuy2026-04-10
Leerink Partners
ReiteratedOutperform2026-01-28
Piper Sandler
ReiteratedOverweight2026-01-16
B of A Securities
ReiteratedBuy2025-08-05
Cantor Fitzgerald
ReiteratedOverweight2025-02-19
Truist Securities
ReiteratedBuy2025-02-19
Citigroup
ReiteratedBuy2024-05-07
BTIG
ReiteratedBuy2022-12-23
SVB Leerink
ReiteratedOutperform2022-11-29
Loop Capital
ReiteratedBuy2022-11-01
Cowen & Co.
ReiteratedOutperform2022-06-29
Berenberg
ReiteratedBuy2021-06-10
H.C. Wainwright
ReiteratedBuy2019-12-30
William Blair
ReiteratedOutperform2019-09-18
BTIG Research
ReiteratedBuy2017-05-19
Brean Capital
ReiteratedBuy2015-12-17
One row per institution, most recent rating